tm logo
BRIDGE PHARMA
Live/Pending
FINAL REFUSAL - MAILED

mailed

on 07 Mar 2024

Last Applicant/ Owned by

701 Brickell Avenue, Suite 1490

Miami

FL

33131

Serial Number

97759618 filed on 18th Jan 2023

Registration Number

N/A

Correspondent Address

Lisel M. Ferguson

PROCOPIO CORY HARGREAVES & SAVITCH LLP

525 B STREET, SUITE 2200

SAN DIEGO,CA 92101

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PHARMA"

BRIDGE PHARMA

Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain "PHARMA" Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain Custom manufacture of theraRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Class [005]
Pharmaceutical Products


Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain

Mark Details


Serial Number

No 97759618

Mark Type

No Service Mark

Attorney Docket Number

No 12850104US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Mar 2024FINAL REFUSAL WRITTEN
07th Mar 2024FINAL REFUSAL E-MAILED
07th Mar 2024NOTIFICATION OF FINAL REFUSAL EMAILED
25th Jan 2024TEAS/EMAIL CORRESPONDENCE ENTERED
24th Jan 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
24th Jan 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
25th Oct 2023NON-FINAL ACTION WRITTEN
25th Oct 2023NON-FINAL ACTION E-MAILED
25th Oct 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
16th Oct 2023ASSIGNED TO EXAMINER